1. Home
  2. Blog
  3. Axol Bioscience Announces Custom Cell and Tissue Sourcing Service

Axol Bioscience Announces Custom Cell and Tissue Sourcing Service

Axol Bioscience Announces Custom Cell and Tissue Sourcing Service


The human cell culture specialists launch primary cell and tissue sourcing service for difficult-to-find samples

Cambridge, UK, 28 April 2016: Axol Bioscience, a biotechnology company specialising in the supply of primary and stem cell-derived human cells for use in disease modelling and drug discovery, announces the launch of its Custom Cell and Tissue Sourcing service. The new service will be of use to all researchers working in these areas who require access to primary human cells and tissues. These can be difficult to obtain, especially when studying rare diseases or specific donor criteria are required. Axol aims to provide cells and tissues that meet specific research requirements to enable the development of highly relevant cellular models that better reflect the biology of the tissue or disease.

Axol Custom Cell and Tissue Sourcing includes a broad range of human primary cell and tissue types from both healthy individuals and patient donors. The company specialises in sourcing a wide variety of primary cancer tissues. Many of these samples are collected prior to treatment so the tissue is naïve, thereby reducing the influence of potentially confounding variables when studying the effects of anti-cancer compounds on these cells. Axol also provides biological specimens such as blood and tissues from a wide range of other clinical indications. These include autoimmune diseases (e.g. type I diabetes), digestive tract (e.g. Crohn’s disease), neurological (e.g. Parkinson’s, Huntington’s or Alzheimer’s diseases), pulmonary (e.g. asthma or chronic obstructive pulmonary disease (COPD)), cardiovascular, kidney and bladder disorders, liver cirrhosis and skin conditions.

Axol already offers a growing range of human primary cells including hepatocytes, fibroblasts, hematopoietic, epithelial, muscle and mesenchymal stem cells. Dr Michael Prater, Primary Cells Product Manager, Axol Bioscience said: ‘We are excited to be expanding our primary product portfolio by providing an extensive resource of biological specimens from various backgrounds. We’re dedicated to ensuring our customers have the tools they need to generate biologically relevant cell-based assays that advance their research and we will endeavour to source samples that meet their experimental requirements’.

All primary human cells provided by Axol are cryopreserved. Tissue samples are available as either fresh frozen, formalin-fixed or paraffin-embedded. The complete list of Custom Cell and Tissue Sourcing capabilities, including cell types, tissue sources and donors, can be found in the online brochure here.

For further information, please visit the Custom Cell and Tissue Sourcing webpage.

Press enquiries

Dr. Michelle Ricketts

Axol Bioscience

T: +44 1223 751051

E: m.ricketts@axolbio.com

W: axolbio.com


About Axol Bioscience

Axol was co-founded by Jonathan Milner, PhD and Yichen Shi, PhD whose combined expertise and entrepreneurial spirit was the driving force behind the creation of Axol – where innovation, quality and customer service are key. Axol produces highly validated, human cells and critical reagents such as media and growth supplements. The Axol team is passionate about great science, delivering superb customer service and support and innovating future products to help customers advance their research faster. To find out more, visit axolbio.com.

Axol Bioscience Appoints Chief Business Officer
Axol Bioscience Appoints Steve Finkbeiner as Scientific Advisory Board Member